Argonaute-2 promotes miR-18a entry in human brain endothelial cells

Journal of the American Heart Association

Volumn 3, Issue 3, 2014, Pages

  Ferreira, Raquel ^a   Santos, Tiago ^a   Amar, Arun ^a   Gong, Alex ^a   Chen, Thomas C ^a   Tahara, Stanley M ^a   Giannotta, Steven L ^a   Hofman, Florence M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Angiogenesis; Argonaute 2; Arteriovenous malformation; Brain endothelial cells; MiR 18a

Indexed keywords

ARGONAUTE 2 PROTEIN; MICRORNA; MICRORNA 18A; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VASCULOTROPIN A; ARGONAUTE PROTEIN; EIF2C2 PROTEIN, HUMAN; MIRN18A MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAIN ARTERIOVENOUS MALFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MALE; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; ANIMAL; BRAIN; CELL CULTURE; CYTOLOGY; METABOLISM; NUDE MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; VASCULARIZATION; WESTERN BLOTTING;

ANIMALS; ARGONAUTE PROTEINS; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MICE, NUDE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84939462991     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000968     Document Type: Article

References (25)

1. Yashar P, Amar AP, Giannotta SL, Yu C, Pagnini PG, Liu CY, Apuzzo ML. Cerebral arteriovenous malformations: issues of the interplay between stereotactic radiosurgery and endovascular surgical therapy. World Neurosurg. 2011;75:638-647.
2. Haw CS, terBrugge K, Willinsky R, Tomlinson G. Complications of embolization of arteriovenous malformations of the brain. J Neurosurg. 2006;104:226-232.
3. Jabbour MN, Elder JB, Samuelson CG, Khashabi S, Hofman FM, Giannotta SL, Liu CY. Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells. Neurosurgery. 2009;64:139-146.
4. Stapleton CJ, Armstrong DL, Zidovetzki R, Liu CY, Giannotta SL, Hofman FM. Thrombospondin-1 modulates the angiogenic phenotype of human cerebral arteriovenous malformation endothelial cells. Neurosurgery. 2011;68:1342-1353.
5. Ferreira R, Santos T, Amar A, Tahara SM, Chen TC, Giannotta SL, Hofman FM. Microrna-18a improves human cerebral arteriovenous malformation endothelial cell function. Stroke. 2014;45:293-297.
6. Bartel DP. Micrornas: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
7. Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microrna: a new source of biomarkers. Mutat Res. 2011;717:85-90.
8. Boon RA, Vickers KC. Intercellular transport of micrornas. Arterioscler Thromb Vasc Biol. 2013;33:186-192.
9. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ. Argonaute2 is the catalytic engine of mammalian rnai. Science. 2004;305:1437-1441.
10. Virrey JJ, Golden EB, Sivakumar W, Wang W, Pen L, Schonthal AH, Hofman FM, Chen TC. Glioma-associated endothelial cells are chemoresistant to temozolomide. J Neurooncol. 2009;95:13-22.
11. Creemers EE, Tijsen AJ, Pinto YM. Circulating micrornas: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012;110:483-495.
12. Lundberg M, Johansson M. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem Biophys Res Commun. 2002;291:367-371.
13. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of micrornas in living cells. J Biol Chem. 2010;285:17442-17452.
14. Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, Shuman MA. Anti-vegf antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia. 2000;2:306-314.
15. Fabbri M. Tlrs as mirna receptors. Cancer Res. 2012;72:6333-6337.
16. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microrna spectrum in 12 body fluids. Clin Chem. 2010;56:1733-1741.
17. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK. RNA interference in the clinic: challenges and future directions. Nat Rev Cancer. 2011;11:59-67.
18. Nana-Sinkam SP, Croce CM. Micrornas as therapeutic targets in cancer. Transl Res. 2011;157:216-225.
19. Huynh C, Segura MF, Gaziel-Sovran A, Menendez S, Darvishian F, Chiriboga L, Levin B, Meruelo D, Osman I, Zavadil J, Marcusson EG, Hernando E. Efficient in vivo microrna targeting of liver metastasis. Oncogene. 2011;30:1481-1488.
20. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H. Therapeutic silencing of microrna-122 in primates with chronic hepatitis c virus infection. Science. 2010;327:198-201.
21. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microrna. Nucleic Acids Res. 2011;39:7223-7233.
22. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating micrornas independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108:5003-5008.
23. Czech B, Hannon GJ. Small rna sorting: matchmaking for argonautes. Nat Rev Genet. 2011;12:19-31.
24. Zhou J, Li YS, Nguyen P, Wang KC, Weiss A, Kuo YC, Chiu JJ, Shyy JY, Chien S. Regulation of vascular smooth muscle cell turnover by endothelial cellsecreted microrna-126: role of shear stress. Circ Res. 2013;113:40-51.
25. Dominska M, Dykxhoorn DM. Breaking down the barrierssirna delivery and endosome escape. J Cell Sci. 2010;123:1183-1189.